|Articles|April 1, 2012
- Pharmaceutical Executive-04-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - April 2012
Come Rain or Shine
Advertisement
Articles in this issue
over 14 years ago
HBA Woman of the Year 2012over 14 years ago
Scotland, Independence, and Pharmaover 14 years ago
Emerging Markets: Setting a New Agendaover 14 years ago
Shortages and Sunshineover 14 years ago
Pharm Exec Ad Stars 2012over 14 years ago
Providing Access Nowover 14 years ago
Navigating M&A Complexitiesover 14 years ago
Country Report: Ukraineover 14 years ago
Think Digital FirstAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond Amyloid, Part One (of two): Tau and Microglia Redefine the Alzheimer’s Pipeline
2
What the Peptide Advisory Vote Actually Means: Q&A with James LaValle
3
Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321
4
M&A Roundup: IntraGel & UroGen Sign Collaboration & Investment Agreements, Lupin & Tenpoint Form Commercialization Collaboration
5